Analyzing genetic markers in patients with intellectual disabilities

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to analyze genetic and biological markers in patients diagnosed with intellectual disabilities of genetic origin, such as Down Syndrome. Blood and skin samples will be collected from participants at the Institut Jérôme Lejeune, where researchers will identify and study the mechanisms of modified genes and the cellular pathways involved in these disorders. The goal is to enhance understanding of the complications and pathologies associated with genetic intellectual disabilities. This research could lead to improved diagnostic and therapeutic strategies for affected individuals.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patient diagnosed with an intellectual disability of genetic origin
* Patient of all ages coming for consultation at the Institut Jérôme Lejeune
* Patient whose parents or legal representative have received and understood the information document and signed the informed consent for a sample for the research project.
* Patient affiliated to a social security scheme

Exclusion Criteria:

* Parents unable to find out about the constraints related to the study
* Refusal of informed patient participation
* Pregnant, parturient and nursing mothers
* Persons deprived of their liberty by judicial or administrative decision

Where it's running

• Institut Jérôme Lejeune
  Paris, France Recruiting

Study contacts

• Study coordinator: Sophie Durand
• Email: sophie.durand@institutlejeune.org
• Phone: +33156586300

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Inclusive physical activity program for adults with intellectual disabilities

  This study is testing a new fitness program for adults with intellectual disabilities to see if it helps them be more active and feel better over 16 weeks.

  Recruiting University of North Carolina, Chapel Hill · Fayetteville, Arkansas and 1 other locations · NCT06740162

• Leopard: using multi-omics to boost genetic diagnosis for neurodevelopmental disorders

  This study tests a multi-omics approach to find genetic explanations for neurodevelopmental disorders in people with moderate-to-severe intellectual disability.

  Recruiting Istituto Giannina Gaslini · Genova · NCT07884227

• Kinematic analysis of hand and arm movement in kids with Down syndrome, CP and healthy children

  This study tests how well an instrumented Box and Block Test and motion tracking can measure upper-limb movement in healthy kids and those with pyramidal hemisyndrome or Down syndrome.

  Recruiting IRCCS San Raffaele Roma · Rome, Italiy · NCT07875127

• Sensory integration to help balance and movement in kids with Down syndrome

  Aimed at seeing if adding sensory integration to physical therapy helps improve gross motor skills and balance in children with Down syndrome.

  Recruiting Cairo University · Cairo · NCT07785011

• Collaboration for Down Syndrome Progress (CDP) in people with Down syndrome

  A long-term study following people with Down syndrome of all ages to see how health and everyday life change over time.

  Recruiting RTI International · Orange, California and 15 other locations · NCT07625579

• Regulating Together for Emotion Dysregulation in ASD and Intellectual Disability (group therapy)

  This study tests a group therapy program for kids with autism and co-occurring intellectual disability to help them manage irritability and aggression, with sessions for both children and their caregivers.

  Recruiting Children's Mercy Hospital Kansas City · Kansas City, Missouri · NCT07624448

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.